Liver

Nonalcoholic steatohepatitis (NASH), a severe form of nonalcoholic fatty liver disease (NAFLD), poses significant health challenges due to liver inflammation and potential progression to cirrhosis or liver failure. With increasing prevalence, particularly among those with diabetes or obesity, understanding its risks, treatment options, and diagnostic challenges is critical for effective management and preventative measures. Understanding […]